Skip to Content
Find More Like This
Return to Search

Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making

United States Patent

October 23, 2012
View the Complete Patent at the US Patent & Trademark Office
U.S. Department of Energy - Visit the Office of the Assistant General Counsel for Technology Transfer & Intellectual Property Website
The present disclosure relates to novel compounds having the structural Formulas (1a,1b), stereoisomers, tautomers, racemics, prodrugs, metabolites thereof, or pharmaceutically acceptable salt and/or solvate thereof as chemotherapy agents for treating of cancer, particularly androgen-independent prostate cancer. The disclosure also relates to methods for preparing said compounds, and to pharmaceutical compositions comprising said compounds. ##STR00001##
Gakh; Andrei A (Bethesda, MD), Vovk; Mykhaylo V. (Kyiv, UA), Mel'nychenko; Nina V. (Kyiv, UA), Sukach; Volodymyr A. (Brovary, UA)
U.S. Department of Energy (Washington, DC)
13/ 422,158
March 16, 2012
CONTRACTUAL ORIGIN OF THE INVENTION This invention was made with United States Government support under a U.S. Department of Energy contract. The U.S. Government has certain rights in the present invention pursuant to Contract No. #200c between the Department of Energy (DOE), Science and Technology Center in Ukraine (STCU) and the Institute of Organic Chemistry of National Academy of Sciences of Ukraine, dated Jul. 1, 2008.